CAIRO: The Egyptian market will receive a new batch of the hepatitis C
treatment medication Sovaldi next June after being manufactured
locally, Youm 7 reported Sunday.
Pharmed Healthcare Executive Director, Mohamed Mabrouk, said that his
firm will deliver 500,000 bottles after being manufactured with local
“This step will give the Egyptian market an unprecedented motive,” he said.
Labels: access to treatment, Egypt, hepatitis C, Sovaldi